The Plan

The programme will take place over one week on-site in India in February of 2026. The exact dates will be announced soon. Prior to the on-site week, virtual sessions will be held to ensure a smooth experience and thorough preparation for the participants. The overall programme includes the following components:

• Preparatory Activities:
  • Engage in online modules and discussions with Swissnex coaches four to six weeks before the on-site visit to India.
  • Develop clear milestones for an impactful engagement during the on-site week.
• Programme Stipend:
  • Travel grants of CHF 3,000 for the Market Validation Camp and CHF 6,000 for the Market Entry Camp are provided by Innosuisse to selected startups.
• Strategic Meetings:
  • Participate in tailored bilateral meetings with relevant actors in the field of healthtech in India.
  • Receive support through briefing and debriefing sessions with a Swissnex coach to fine-tune your approach.
• Visibility:
  • Present your innovations to at BioAsia 2026, a dedicated healthcare conference in Hyderabad.
• Post-Visit Support:
  • Receive 15 days of follow-up assistance to help you capitalise on the connections and opportunities created during the programme.

Why India?

India’s healthcare sector, valued at USD 372 billion in FY23 and projected to reach USD 638 billion by 2025, offers Swiss startups a high-growth environment for innovation. With over 70,000 hospitals and a robust healthtech ecosystem of 10,000+ startups in diagnostics, digital health, medtech and AI based solutions, the country provides access to diverse patient populations, real-world testing environments and co-development partners.

Known as the “Contract Research Organization (CRO) of the world”, India enables faster, cost-effective R&D and clinical validation. Swiss startups can tap into this ecosystem to develop precision diagnostics across the spectrum—from ultra-affordable tools for mass use to high-end solutions for personalised care. Its deep clinical infrastructure and adaptive regulatory pathways support rapid prototyping, validation and scaling.

The recent Trade and Economic Partnership Agreement (TEPA) between Switzerland and India further reduces entry barriers, paving the way for Swiss healthtech innovations to gain traction in India and scale globally.

Who Can Apply?

Healthtech startups headquartered in Switzerland and incorporated within the last five years are eligible to apply.

We encourage applications from early-stage to growth-stage startups that have developed a late-stage prototype and are ready for market validation. Swiss startups that are enrolled or currently in the Innosuisse Coaching Program (initial, core, or scale-up coaching)

To register your interest, fill out this form. The deadline is 20 September. For any questions or clarifications, please contact the Innovation team. Their details can be found below.

By participating in Healthtech India 2026 Swiss startups can enhance their market presence, forge valuable partnerships with Indian industry leaders, and contribute to the global evolution of healthcare technologies.